Prof. Yongzhong Wu 吴永忠
Chief Physician, Professor
Department of Radiation Oncology, Chongqing University Cancer Hospital, Chongqing
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Early diagnosis and treatment of lung cancer; standardized and comprehensive management of malignancies, especially locally advanced non-small cell lung cancer. Expertise in radiotherapy, gene sensitization, and combined immunotherapy or targeted therapy.
Dr. Wu is Chief Physician, Professor, and Director of Radiotherapy at Chongqing University Cancer Hospital. Holding a medical doctorate, Dr. Wu leads research in gene therapy and radiotherapy sensitization. Dr. Wu has led or participated in seven research projects, authored over 50 papers, and contributed to six textbooks.
Professional roles
- Standing Committee Member, Radiation Oncology Branch, Chinese Medical Association
- Standing Committee Member, Radiotherapy Committee, China Anti-Cancer Association
- Vice Chair, Oncology Committee, Chongqing Medical Association
- Editorial Board Member, Chinese Journal of Radiation Oncology
Name order: in Chinese the family name comes first (Wu Yongzhong). Papers usually list the name as Yongzhong Wu or Wu Y.
Selected publications
91 papers on PubMed matched by name and affiliation; 28 as first or senior author since 2016. Most recent first- or senior-author papers:
- J Transl Med, 2026 (senior author): GATA5 impedes NSCLC progression by activating SDPR and repressing CNR1 expression. PubMed 42968152
- BMC Cancer, 2026 (senior author): Nomogram-based prediction of checkpoint inhibitor pneumonitis in lung cancer patients. PubMed 41680658
- Int J Surg, 2026 (senior author): Development and validation of an explainable machine learning model for predicting postoperative venous thromboembolism in esophageal cancer. PubMed 40990679
- J Evid Based Med, 2025 (senior author): Epidemiological Trends and Disease Burden of Tracheal, Bronchial, and Lung Cancer in China and Globally From 1990 to 2021: Results From the Global Burden of Disease Study 2021. PubMed 41222412
- Cell Death Dis, 2025 (senior author): HAT1 functions as a lactyltransferase and mediates RPA1 lactylation to promote DNA repair and radioresistance in lung adenocarcinoma. PubMed 41271679
- J Thorac Dis, 2025 (senior author): EGFR-TKIs with or without stereotactic body radiotherapy to primary lesion in the advanced EGFR-mutated non-small cell lung cancer. PubMed 41229820
- Thorax, 2025 (senior author): Association between ultra-processed food consumption and lung cancer risk: a population-based cohort study. PubMed 40730472
- Front Pain Res (Lausanne), 2025 (senior author): Electroacupuncture therapy and bone cancer pain relief: experimental study on analgesic mechanisms in rats. PubMed 41112967
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion